Tobacco News and Research

RSS

Cochrane Review looks at different ways to use nicotine replacement therapies

New evidence published in the Cochrane Library provides high quality evidence that people who use a combination of nicotine replacement therapies (a patch plus a short acting form, such as gum or lozenge) are more likely to successfully quit smoking than people who use a single form of the medicine.

24 Apr 2019

Traditional and e-cigarette users may be more receptive to smoking cessation interventions

A study by MassGeneral Hospital for Children researchers finds that parents who use both traditional cigarettes and e-cigarettes may be more receptive to smoking cessation interventions than parents who only smoke traditional cigarettes.

23 Apr 2019

Survey: Half of all American workplaces offer health and wellness programs

Workplace health promotion programs are increasing in the U.S., according to researchers at the University of North Carolina at Chapel Hill's Gillings School of Global Public Health, the Centers for Disease Control and Prevention, and RTI International.

22 Apr 2019

FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse the effects of an opioid overdose.

22 Apr 2019

FDA authorizes marketing of first medical device to treat ADHD

The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder.

22 Apr 2019

Men who have a resting heart rate of 75 bpm are twice as likely to die early

Having a resting heart rate of 75 beats per minute (bpm) during middle-age may double the risk for early death, according to new research.

17 Apr 2019

FDA orders surgical mesh manufacturers to stop selling and distributing their products in the U.S.

The U.S. Food and Drug Administration today ordered the manufacturers of all remaining surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse (POP) to stop selling and distributing their products in the U.S. immediately.

17 Apr 2019

Cause of cancer is 'written' in our DNA as unique 'fingerprints'

Scientists have discovered that the cause of cancer is “written” within the DNA of tumors, a finding that could help doctors to decide on the best treatment for a patient.

16 Apr 2019

Smelling your favorite food or beverage could curb cigarette cravings

Struggling to curb that cigarette habit? A new study has found that people trying quit smoking may benefit from inhaling pleasant-smelling aromas like peppermint, chocolate, or vanilla.

16 Apr 2019

New catalog of DNA mutation 'fingerprints' could help doctors pinpoint cancer culprits

Scientists in Cambridge and London have developed a catalog of DNA mutation 'fingerprints' that could help doctors pinpoint the environmental culprit responsible for a patient's tumor - including showing some of the fingerprints left in lung tumors by specific chemicals found in tobacco smoke.

16 Apr 2019

Reducing smoking among Medicaid recipients by 1% could result in $2.6 billion savings

Reducing smoking, and its associated health effects, among Medicaid recipients in each state by just 1 percent would result in $2.6 billion in total Medicaid savings the following year, according to new research by UC San Francisco.

12 Apr 2019

FDA approves new treatment for adults with metastatic bladder cancer

The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy.

12 Apr 2019

FDA offers funding to create the most advanced living mimicry of a human lung

The University of Colorado Anschutz Medical Campus announced the funding of $3.4 million by the U.S. Food and Drug Administration to create the most advanced living mimicry of a human lung to identify toxicity and cancer-causing potential of emerging tobacco products.

12 Apr 2019

Tax increase on tobacco, alcohol, and SSBs could save millions of lives

Low-and-middle income countries continue to face a growing burden of morbidity and mortality attributable to the consumption of tobacco, alcohol and of sugar sweetened beverages.

12 Apr 2019

FDA issues safety labeling changes for female sexual dysfunction treatment

The U.S. Food and Drug Administration today issued a safety labeling change order to Sprout Pharmaceuticals for their drug, Addyi (flibanserin), that requires the company to revise important safety information that women and their health care professionals need to have when considering use of the drug.

12 Apr 2019

FDA warns against using uncleared medical devices to assess or diagnose concussion

Today, the U.S. Food and Drug Administration is warning the public not to use medical devices marketed to consumers that claim to help assess, diagnose or manage head injury, including concussion, traumatic brain injury (TBI) or mild TBI.

11 Apr 2019

FDA, EPA, and USDA announce strategy to address food waste

Today, as part of the Trump Administration's Winning on Reducing Food Waste Month, the U.S. Department of Agriculture, the U.S. Environmental Protection Agency, and the U.S. Food and Drug Administration announced the release of a federal interagency strategy to address food waste.

10 Apr 2019

$FDA approves new osteoporosis drug for postmenopausal women with high fracture risk$

FDA approves new osteoporosis drug for postmenopausal women with high fracture risk

The U.S. Food and Drug Administration today approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture).

9 Apr 2019

Nicotine concentration in JUUL e-cigarette products is dangerously high, finds study

Little is known about the potential health effects of JUUL e-cigarette products that have recently risen in popularity, especially among adolescents.

9 Apr 2019

Forensic researchers discover key factors relating to premature adult deaths

About two-thirds of the adults dying prematurely from natural causes did not seek medical help within the 30 days preceding their death, reported forensic researchers from The University of Texas Health Science Center at Houston and the Harris County Institute of Forensic Sciences.

9 Apr 2019

Tobacco News and Research

Cochrane Review looks at different ways to use nicotine replacement therapies

Traditional and e-cigarette users may be more receptive to smoking cessation interventions

Survey: Half of all American workplaces offer health and wellness programs

FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

FDA authorizes marketing of first medical device to treat ADHD

Men who have a resting heart rate of 75 bpm are twice as likely to die early

FDA orders surgical mesh manufacturers to stop selling and distributing their products in the U.S.

Cause of cancer is 'written' in our DNA as unique 'fingerprints'

Smelling your favorite food or beverage could curb cigarette cravings

New catalog of DNA mutation 'fingerprints' could help doctors pinpoint cancer culprits

Reducing smoking among Medicaid recipients by 1% could result in $2.6 billion savings

FDA approves new treatment for adults with metastatic bladder cancer

FDA offers funding to create the most advanced living mimicry of a human lung

Tax increase on tobacco, alcohol, and SSBs could save millions of lives

FDA issues safety labeling changes for female sexual dysfunction treatment

FDA warns against using uncleared medical devices to assess or diagnose concussion

FDA, EPA, and USDA announce strategy to address food waste

FDA approves new osteoporosis drug for postmenopausal women with high fracture risk

Nicotine concentration in JUUL e-cigarette products is dangerously high, finds study

Forensic researchers discover key factors relating to premature adult deaths

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News